Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in Impaired Fasting Glucose
NCT00364377Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in impaired fasting glucose (IFG), sponsored by Mayo Clinic. Started Aug 2006; status: completed.
02
Drugs
sitagliptin
03
Conditions
impaired fasting glucose (IFG)
Beyond the preview
Go deeper on NCT00364377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364377.